3200 Lakeside Dr.
Santa Clara
CA
95054
USA
(408) 845-3000
Related Content
October 20, 2008 – At TCT last week Abbott announced two-year data from 30 patients in its ABSORB clinical trial ...
October 19, 2008
October 13, 2008 — Data from an independent meta-analysis of Abbott Vascular’s SPIRIT II and SPIRIT III randomized ...
October 13, 2008August 20, 2008 - Diagnostic testing conducted at or near the site of the patient, known as patient-side point-of-care ...
August 19, 2008August 15, 2008 - Abbott and AstraZeneca said this week they entered into an agreement for Abbott to promote AstraZeneca ...
August 14, 2008
The StarClose SE Vascular Closure System is a next-generation vessel closure device engineered to enable fast and secure ...
July 08, 2008June 2, 2008 - Abbott has submitted an application for Seizo Hanbai Shonin (Marketing Authorization License) to Japan's ...
June 01, 2008May 20, 2008 – Abbott launched the StarClose SE Vascular Closure System, a next-generation vessel closure device ...
May 19, 2008
Abbott's StarClose SE Vascular Closure System, a next-generation vessel closure device, is engineered to enable fast and ...
May 19, 2008
Abbott Vascular’s HI-TORQUE WHISPER guidewire is designed to offer a higher level of support to facilitate device ...
May 12, 2008March 13, 2008 – Abbott’s fully bioabsorbable drug-eluting stent for the treatment of coronary artery disease ...
March 16, 2008